TCL Archive Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia September 27, 2013
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR December 2, 1977
TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
